Cell fusion induced by ERVWE1 or measles virus causes cellular senescence

Genes and Development

Volumn 27, Issue 21, 2013, Pages 2356-2366

  Chuprin, Anna ^a   Gal, Hilah ^a   Biron Shental, Tal ^b,c   Biran, Anat ^a   Amiel, Aliza ^b,d   Rozenblatt, Shmuel ^a   Krizhanovsky, Valery ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d BAR ILAN UNIVERSITY   (Israel)

Author keywords

Cell fusion; Cellular senescence; ERVWE1; p53; Placenta; pRb

Indexed keywords

ENDOGENOUS RETROVIRAL FAMILY W ENV (C7) MEMBER 1; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CANCER CELL; CELL AGING; CELL FUSION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; HUMAN; HUMAN CELL; MEASLES; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; SYNCYTIOTROPHOBLAST;

CELL FUSION; CELLULAR SENESCENCE; ERVWE1; P53; PLACENTA; PRB;

CELL AGING; CELL FUSION; CELL LINE; CELL LINE, TUMOR; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE PRODUCTS, ENV; HUMANS; MEASLES; MEASLES VIRUS; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; TROPHOBLASTS;

EID: 84887063977     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.227512.113     Document Type: Article

References (62)

1. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Fumagalli M, Da Costa M, Brown C, Popov N, et al. 2008. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133: 1006-1018.
2. Aksoy O, Chicas A, Zeng T, Zhao Z, McCurrach M, Wang X, Lowe SW. 2012. The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence. Genes Dev 26: 1546-1557.
3. Allsopp RC, Harley CB. 1995. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 219: 130-136.
4. Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, Oren M. 2006. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev 20: 2687-2700.
5. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM. 2011. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479: 232-236.
6. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, et al. 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
7. Blond JL, Lavillette D, Cheynet V, Bouton O, Oriol G, Chapel-Fernandes S, Mandrand B, Mallet F, Cosset FL. 2000. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 74: 3321-3329.
8. Campisi J. 2011. Cellular senescence: Putting the paradoxes in perspective. Curr Opin Genet Dev 21: 107-112.
9. Campisi J, d'Adda di Fagagna F. 2007. Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740.
10. Canino C, Mori F, Cambria A, Diamantini A, Germoni S, Alessandrini G, Borsellino G, Galati R, Battistini L, Blandino R, et al. 2012. SASP mediates chemoresistance and tumorinitiating-activity of mesothelioma cells. Oncogene 31: 3148-3163.
11. Collado M, Serrano M. 2010. Senescence in tumours: Evidence from mice and humans. Nat Rev Cancer 10: 51-57.
12. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. 2008. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6: 2853-2868.
13. Dame JB, Juul SE. 2000. The distribution of receptors for the proinflammatory cytokines interleukin (IL)-6 and IL-8 in the developing human fetus. Early Hum Dev 58: 25-39.
14. De Falco M, Fedele V, Cobellis L, Mastrogiacomo A, Leone S, Giraldi D, De Luca B, Laforgia V, De Luca A. 2004. Immunohistochemical distribution of proteins belonging to the receptor-mediated and the mitochondrial apoptotic pathways in human placenta during gestation. Cell Tissue Res 318: 599-608.
15. Delpeut S, Noyce RS, Siu RW, Richardson CD. 2012. Host factors and measles virus replication. Current opinion in virology 2: 773-783.
16. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A, et al. 2006. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642.
17. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci 92: 9363-9367.
18. Duelli D, Lazebnik Y. 2003. Cell fusion: A hidden enemy? Cancer Cell 3: 445-448.
19. Duelli D, Lazebnik Y. 2007. Cell-to-cell fusion as a link between viruses and cancer. Nat Rev Cancer 7: 968-976.
20. Dupressoir A, Vernochet C, Harper F, Guegan J, Dessen P, Pierron G, Heidmann T. 2011. A pair of co-opted retroviral envelope syncytin genes is required for formation of the twolayered murine placental syncytiotrophoblast. Proc Natl Acad Sci 108: E1164-E1173.
21. Ganem NJ, Pellman D. 2007. Limiting the proliferation of polyploid cells. Cell 131: 437-440.
22. Gorecki M, Rozenblatt S. 1980. Cloning of DNA complementary to the measles virus mRNA encoding nucleocapsid protein. Proc Natl Acad Sci 77: 3686-3690.
23. Gupta AK, Hasler P, Holzgreve W, Gebhardt S, Hahn S. 2005. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol 66: 1146-1154.
24. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, et al. 2006. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12: 1065-1074.
25. Harris H, Miller OJ, Klein G, Worst P, Tachibana T. 1969. Suppression of malignancy by cell fusion. Nature 223: 363-368.
26. Jun JI, Lau LF. 2010. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 12: 676-685.
27. Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova A, et al. 2011. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479: 547-551.
28. Khan SH, Moritsugu J, Wahl GM. 2000. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion. Proc Natl Acad Sci 97: 3266-3271.
29. Knudsen KE, Booth D, Naderi S, Sever-Chroneos Z, Fribourg AF, Hunton IC, Feramisco JR, Wang JY, Knudsen ES. 2000. RBdependent S-phase response to DNA damage. Mol Cell Biol 20: 7751-7763.
30. Krizhanovsky V, Lowe SW. 2009. Stem cells: The promises and perils of p53. Nature 460: 1085-1086.
31. Krizhanovsky V, YonM, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW. 2008. Senescence of activated stellate cells limits liver fibrosis. Cell 134: 657-667.
32. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS. 2008. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133: 1019-1031.
33. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. 2010. The essence of senescence. Genes Dev 24: 2463-2479.
34. Larsen JM, Christensen IJ, Nielsen HJ, Hansen U, Bjerregaard B, Talts JF, Larsson LI. 2009. Syncytin immunoreactivity in colorectal cancer: Potential prognostic impact. Cancer Lett 280: 44-49.
35. Larsson LI, Holck S, Christensen IJ. 2007. Prognostic role of syncytin expression in breast cancer. Hum Pathol 38: 726-731.
36. Larsson LI, Bjerregaard B, Talts JF. 2008. Cell fusions in mammals. Histochem Cell Biol 129: 551-561.
37. Lin EH, Salon C, Brambilla E, Lavillette D, Szecsi J, Cosset FL, Coll JL. 2010. Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: A potential therapy agent for lung cancer. Cancer Gene Ther 17: 256-265.
38. Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA, Krizhanovsky V, et al. 2013. Non-cell-autonomous tumor suppression by p53. Cell 153: 449-460.
39. McKenna E, Traganos F, Zhao H, Darzynkiewicz Z. 2012. Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence. Cell Cycle 11: 3132-3140.
40. Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang XY, Edouard P, Howes S, et al. 2000. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403: 785-789.
41. Moiseeva O, Mallette FA, Mukhopadhyay UK, Moores A, Ferbeyre G. 2006. DNA damage signaling and p53-dependent senescence after prolonged b-interferon stimulation. Mol Biol Cell 17: 1583-1592.
42. Msaouel P, Dispenzieri A, Galanis E. 2009. Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: An overview. Curr Opin Mol Ther 11: 43-53.
43. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716.
44. Narita M, Narita M, Krizhanovsky V, Nunez S, Chicas A, Hearn SA, Myers MP, Lowe SW. 2006. A novel role for highmobility group a proteins in cellular senescence and heterochromatin formation. Cell 126: 503-514.
45. Ogle BM, Cascalho M, Platt JL. 2005. Biological implications of cell fusion. Nat Rev Mol Cell Biol 6: 567-575.
46. Oldstone MB, Lewicki H, Thomas D, Tishon A, Dales S, Patterson J, Manchester M, Homann D, Naniche D, Holz A. 1999. Measles virus infection in a transgenic model: Virus-induced immunosuppression and central nervous system disease. Cell 98: 629-640.
47. Ouseph MM, Li J, Chen HZ, Pecot T, Wenzel P, Thompson JC, Comstock G, Chokshi V, Byrne M, Forde B, et al. 2012. Atypical E2F repressors and activators coordinate placental development. Dev Cell 22: 849-862.
48. Rieder CL, Maiato H. 2004. Stuck in division or passing through: What happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 7: 637-651.
49. Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR, Freund A, Campeau E, Davalos AR, Campisi J. 2009. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 11: 973-979.
50. Rozenblatt S, Gorecki M, Shure H, Prives CL. 1979. Characterization of measles virus-specific proteins synthesized in vivo and in vitro from acutely and persistently infected cells. J Virol 29: 1099-1106.
51. Sagiv A, Biran A, Yon M, Simon J, Lowe SW, Krizhanovsky V. 2013. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene 32: 1971-1977.
52. Sapir A, Avinoam O, Podbilewicz B, Chernomordik LV. 2008. Viral and developmental cell fusion mechanisms: Conservation and divergence. Dev Cell 14: 11-21.
53. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW. 2002. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109: 335-346.
54. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
55. Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, Di Gialleonardo V, Cippitelli M, Fionda C, Petrucci MT, Guarini A, et al. 2009. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113: 3503-3511.
56. Strick R, Ackermann S, Langbein M, Swiatek J, Schubert SW, Hashemolhosseini S, Koscheck T, Fasching PA, Schild RL, Beckmann MW, et al. 2007. Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-b. J Mol Med 85: 23-38.
57. te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. 2002. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62: 1876-1883.
58. Tovar C, Higgins B, Deo D, Kolinsky K, Liu JJ, Heimbrook DC, Vassilev LT. 2010. Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: Implications for therapy. Cell Cycle 9: 3364-3375.
59. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, et al. 1998. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9: 267-276.
60. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. 2008. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132: 363-374.
61. Wu L, de Bruin A, Saavedra HI, Starovic M, Trimboli A, Yang Y, Opavska J, Wilson P, Thompson JC, Ostrowski MC, et al. 2003. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421: 942-947.
62. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW. 2007. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656-660.